We use cookies to provide you a better experience. By continuing to use this website, you consent to the use of cookies in accordance with our Cookie Policy.

Paul Matteis

Paul Matteis

Managing Director, Head of Therapeutics Research



[email protected] | (617) 488-4485 | v-Card | View Coverage

Paul Matteis is Head of the Therapeutics Research Team. He joined Stifel in 2018 as a Managing Director and Senior Analyst. From 2019 to 2023, Paul was repeatedly named a “Runner Up” in Small/Mid Cap Biotechnology, and a "Rising Star" in both 2015 and 2016 by Institutional Investor as part of the publication's All-America Research Team rankings.

Prior to joining Stifel, Paul was a Senior Biotechnology Analyst covering small-cap and mid-cap companies at Leerink, with a focus on neuroscience, central nervous system, and rare disease. He received a B.A. in Psychology from Skidmore College in New York, where he graduated Phi Beta Kappa, after which he worked in a sleep research laboratory at Harvard Medical School.